Skip to main content
Premium Trial:

Request an Annual Quote

The Cancer Cure: It Won't Be Cheap and It Won't Be Easy

Yesterday's New York Times included a series of letters from readers responding to the paper's op-ed on dealing with cancer. Respondents hail from the Fox Chase Cancer Center and the Public Health Research Institute, among others.

An excerpt from one letter:

Scientific discovery that addresses underlying disease mechanisms requires a union of physicians and academic researchers to develop novel approaches that can adroitly explore areas like host genetics while looking out for new etiologic agents.

Unfortunately, such high-risk science that challenges prevailing doctrine has been a casualty in a federal fiscal environment where biomedical financing is approaching 1 in 10 grants.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.